According to Oyster Point Pharma's latest financial reports the company's current earnings are S$19.58 Million. In 2021 the company made an earning of -S$0.14 Billion a decrease over its 2020 earnings that were of -S$97.36 Million. The earnings displayed on this page is the company's Pretax Income.